Viewing Study NCT07462468


Ignite Creation Date: 2026-03-26 @ 3:15 PM
Ignite Modification Date: 2026-03-31 @ 12:26 AM
Study NCT ID: NCT07462468
Status: NOT_YET_RECRUITING
Last Update Posted: 2026-03-13
First Post: 2026-03-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 1 Clinical Study to Evaluate the Safety and Efficacy of WSK-IM02 in Patients With Platinum-resistant Recurrent Ovarian Cancer.
Sponsor: WestVac Biopharma Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module